-

Auna Announces the Successful Redemption of Its 6.500% Senior Secured Notes Due 2025 With the Proceeds of Private Placement of Notes

MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the closing of a private placement of USD 57,826,321 aggregate principal amount of its 10.000% Senior Secured Notes due 2029 (the "Additional 2029 Notes"). The proceeds from the Additional 2029 Notes were used to fully redeem the USD 57,826,321 in aggregate principal amount outstanding of its 6.500% Senior Secured Notes due 2025 at a redemption price of 101.625% of the principal amount thereof plus interest to, but excluding, the redemption date.

The Additional 2029 Notes were issued as additional notes under the indenture governing the outstanding USD 253,010,840 million in aggregate principal amount of the Company’s 10.000% Senior Secured Notes due 2029 issued on December 18, 2023. As a result, the total aggregate principal amount outstanding of the Company's 10.000% Senior Secured Notes due 2029 is USD 310,837,161.

About Auna

Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of September 30, 2024, Auna’s network included 31 healthcare network facilities, including hospitals, outpatient, prevention and wellness facilities with 2,308 beds, and 1.3 million healthcare plans.

For more information visit www.aunainvestors.com

Contacts

Investor Relations Contact
contact@aunainvestors.com

Auna S.A.

NYSE:AUNA

Release Versions

Contacts

Investor Relations Contact
contact@aunainvestors.com

More News From Auna S.A.

Auna Announces 4Q24 and FY 2024 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 (“fourth quarter 2024” or “4Q24”) and full year ended 2024 (“full-year 2024” or “FY24”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unles...

Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey

MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna’s commitment to becoming the leading oncolo...

Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2024 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2024 financial results. Earnings Release Monday, March 10, 2025 Time: After Market Close Conference Call Tuesday, March 11, 2025 Time: 8:00 a.m. ET Quiet Period Monday, February 17 through Monday, March 10, 2025 To participate, please dia...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.